$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

Tocotrienols and tocotrienol-like compounds and methods for their use 원문보기

IPC분류정보
국가/구분 United States(US) Patent 등록
국제특허분류(IPC7판)
  • A61K-031/355
  • C07D-311/22
  • C07D-311/72
출원번호 US-0244215 (1994-08-15)
국제출원번호 PCT/US92/10277 (1992-11-20)
§371/§102 date 19940815 (19940815)
국제공개번호 WO-9309777
발명자 / 주소
  • Lane Ronald H. (Phoenix AZ) Qureshi Asaf A. (Madison WI) Salser Winston A. (Pacific Palisades CA)
출원인 / 주소
  • Lipogenics, Inc. (Scottsdale AZ 02)
인용정보 피인용 횟수 : 64  인용 특허 : 9

초록

The present invention relates to novel tocotrienols and tocotrienol-like compounds displaying biological activity. The tocotrienols and tocotrienol-like compounds of this invention may be conveniently obtained from biological sources or by chemical synthesis and may be used in pharmaceutical composi

대표청구항

A tocotrienol comprising 3,4-dihydro-2-(4,8,12-trimethyltrideca-3′(E), 7′(E), 11′-trienyl)-2H-1-benzopyran-6-ol), and having the structure: [Figure] A tocotrienol comprising: [Figure] A composition comprising a tocotrienol compound resulting from a process comprising the steps of: stabilizing a biol

이 특허에 인용된 특허 (9)

  1. Wang, Jonas C. T., Compositions and method for stabilization of anthralin comprising the addition of an oil soluble antioxidant and an anionic surfactant.
  2. Ohgaki Kazunari (Nara JPX) Katayama Takashi (Toyonaka JPX), Extractive separation method.
  3. Pearce Bradley C. (East Hampton CT), Farnesylated tetrahydro-naphthalenols as hypolipidemic agents.
  4. Pearce Bradley C. (East Hampton CT), Farnesylated tetrahydro-naphthalenols as hypolipidemic agents.
  5. Schmidt Douglass N. (Grosse Ile MI), Free-flowing, high density, fat soluble vitamin powders with improved stability.
  6. Marshall Lisa A. (Wayne PA) Steiner Kurt E. (Devon PA) Schiehser Guy A. (Malvern PA), Phospholipase A2 inhibitors.
  7. Pearce Bradley C. (East Hampton CT), Tocotrienol analogs in the treatment of hypercholesterolemia and hyperlipidemia.
  8. Wright John J. (North Guilford CT) Pearce Bradley C. (East Hampton CT) Parker Rex (Branford CT) Qureshi Asaf A. (Madison WI), Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders.
  9. Wright John J. (North Guilford CT) Pearce Bradley C. (East Hampton CT) Parker Rex (Branford CT) Qureshi Asaf A. (Madison WI), Tocotrienols in the treatment of hypercholesterolemia, hyperlipidemia and thromboembolic disorders.

이 특허를 인용한 특허 (64)

  1. Teirstein, Paul S.; Carpenter, Kenneth W.; Szinai, Istvan; Schwartz, David A., Animal model for detection of vulnerable plaques.
  2. Berry Christopher J.,THX ; Bierenbaum Marvin L., Anticholesterolemic edible oil.
  3. Wang, Bing; Chen, Jian, Chroman derivatives.
  4. Wang, Bing; Walkinshaw, Gail; Boddupalli, Sekhar; Elizarov, Arkadij M.; Jin, Xianming; Li, Xianfeng; James, Donald R.; Song, Jiangao; Chen, Jian; Zhang, Wei, Chroman derivatives.
  5. Wang, Bing; Walkinshaw, Gail; James, Donald R., Chroman derivatives.
  6. Udell, Ronald G., Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing.
  7. Guthrie, Najla, Compositions and methods for glycemic control of subjects with impaired fasting glucose.
  8. Guthrie, Najla, Compositions and methods for glycemic control of subjects with impaired fasting glucose.
  9. Miljkovic,Dusan; Pietrzkowski,Zbigniew, Compositions and methods for treating NIDDM and other conditions and disorders associated with AMPK regulation.
  10. Guthrie, Najla; Kurowska, Elzbieta Maria; Manthey, John A., Compositions and methods of treating, reducing and preventing cardiovascular diseases and disorders with polymethoxyflavones.
  11. Bromley, Philip J., Compositions containing non-polar compounds.
  12. Bromley, Philip J., Compositions containing non-polar compounds.
  13. Bromley, Philip J., Compositions containing non-polar compounds.
  14. Bromley, Philip J., Compositions containing non-polar compounds.
  15. Bromley, Philip J., Compositions containing non-polar compounds.
  16. Nawar, Wassef W., Cranberry seed oil extract and compositions containing components thereof.
  17. Nawar, Wassef W., Cranberry seed oil extract and compositions containing components thereof.
  18. Nawar, Wassef W., Cranberry seed oil extract and compositions containing components thereof.
  19. Rich,Mel; Udell,Ronald G.; Hari,Siva P., Formulation and delivery method to enhance antioxidant potency of Vitamin E.
  20. Rich, Melvin Lee; Udell, Ronald G.; Hari, Siva P., Formulation and delivery method to enhance antioxidant potency of vitamin E.
  21. Rich, Melvin Lee; Udell, Ronald G.; Hari, Siva P., Formulation and delivery method to enhance antioxidant potency of vitamin E.
  22. Rich,Melvin; Udell,Ronald G.; Hari,Siva P., Formulation to enhance antioxidant potency of Vitamin E.
  23. Ho,David Sue San; Yuen,Kah Hay; Wong,Jia Woei; Lim,Ai Beoy, Hair growth formulation.
  24. Cheruvanky Rukmini ; McPeak Patricia ; Cherukuri Reddy Sastry V. ; Lynch Ike E., Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis.
  25. Cheruvanky, Rukmini; McPeak, Patricia; Cherukuri, Reddy Sastry V.; Lynch, Ike; Qureshi, Asaf A., Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis.
  26. Cheruvanky, Rukmini; McPeak, Patricia; Cherukuri, Reddy Sastry V.; Lynch, Ike; Qureshi, Asaf A., Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis.
  27. Rukmini Cheruvanky ; Patricia McPeak ; Reddy Sastry V. Cherukuri ; Ike Lynch ; Asaf A. Qureshi, Method for treating hypercholesterolemia, hyperlipidemia, and atherosclerosis.
  28. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  29. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  30. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  31. Fantuzzi, Michael, Method of making a soft gel capsule comprising CoQ-10 solubilized in a monoterpene.
  32. Charles E. Elson, Method of suppressing tumor growth with combinations of isoprenoids and statins.
  33. Elson Charles E., Method of suppressing tumor growth with combinations of isoprenoids and statins.
  34. Sen, Chandan; Roy, Sashwati; Khanna, Savita; Rink, Cameron, Methods for treating burn and scar injury using tocotrienol compositions.
  35. Naguib, Yousry M. A.; Udell, Ronald G.; Passwater, Jr., Richard A.; Rich, Melvin Lee, Natural vitamin E compositions with superior antioxidant potency.
  36. Naguib,Yousry M. A.; Udell,Ronald G.; Passwater, Jr.,Richard A.; Rich,Melvin Lee, Natural vitamin E compositions with superior antioxidant potency.
  37. Naguib,Yousry M. A.; Udell,Ronald G.; Passwater, Jr.,Richard A.; Rich,Melvin Lee, Natural vitamin E compositions with superior antioxidant potency.
  38. Compadre, Cesar M.; Breen, Philip; Aykin-Burns, Nukhet; Hauer-Jensen, Martin; Enriquez, Raul G.; Kharade, Sujay; Malagon, Omar; Ordonez, Yadira; Ojeda, Edgar; Thakkar, Shraddha; Pineda, E. Nathalie; Jones, Darin, Preparation and use of a composition for prevention and mitigation of the effects of radiation.
  39. Hyatt John Anthony, Preparation of tocopherols.
  40. Cherukuri Reddy Sastry V. ; Cheruvanky Rukmini ; Lynch Ike ; McPeak Daniel L., Process for obtaining micronutrient enriched rice bran oil.
  41. Howard, Luke, Process of producing purified gamma- and delta-tocotrienols from tocol-rich oils or distillates.
  42. Lane Ronald H. ; Becker Kenneth W. ; Qureshi Asaf A. ; Wells D. Michael, Processes for recovering tocotrienols, tocopherols and tocotrienol-like compounds.
  43. Fantuzzi, Michael, Solubilized CoQ-10.
  44. Fantuzzi, Michael, Solubilized CoQ-10.
  45. Fantuzzi, Michael, Solubilized CoQ-10.
  46. Fantuzzi, Michael, Solubilized CoQ-10.
  47. Fantuzzi, Michael, Solubilized CoQ-10.
  48. Fantuzzi, Michael, Solubilized CoQ-10.
  49. Fantuzzi, Michael, Solubilized CoQ-10.
  50. Chu, Daniel T. W.; Chen, Jian; Zhang, Wei; Li, Xianfeng; Song, Jiangao; Wang, Bing; Cong, Qiang; James, Donald R., Spiro derivatives as lipoxygenase inhibitors.
  51. McPeak Patricia ; Cheruvanky Rukmini ; Cherukuri Reddy Sastry V., Supportive therapy for diabetes, hyperglycemia and hypoglycemia.
  52. El Sayed, Khalid A.; Sylvester, Paul W., Tocotrienol esters.
  53. Lane Ronald H. ; Qureshi Asaf A. ; Salser Winston A., Tocotrienols and tocotrienol-like compounds and methods for their use.
  54. Lane Ronald H. ; Qureshi Asaf A. ; Salser Winston A., Tocotrienols and tocotrienol-like compounds and methods for their use.
  55. Lane Ronald H. ; Qureshi Asaf A. ; Salser Winston A., Tocotrienols and tocotrienol-like compounds and methods for their use.
  56. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
  57. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
  58. Fantuzzi, Michael, Ubiquinol and alpha lipoic acid compositions.
  59. Liao James K. ; Laufs Ulrich,DEX ; Endres Matthias,DEX ; Moskowitz Michael A., Upregulation of Type III endothelial cell Nitric Oxide Synthase by HMG-CoA reductase inhibitors.
  60. Liao James K., Upregulation of Type III endothelial cell nitric oxide synthase by rho GTPase function inhibitors.
  61. James K. Liao, Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization.
  62. Liao, James K., Upregulation of type III endothelial cell nitric oxide synthase by agents that disrupt actin cytoskeletal organization.
  63. Rodriguez Rolando Perez,CUX ; Molina Luis Enrique Fernandez,CUX ; Rodriguez Gilda Marquina,CUX ; Perez Adriana Carr,CUX ; Hernandez Oscar Gonzalo Valiente,CUX, Vaccine compositions for eliciting an immune response against N-acetylated gangliosides and their use for cancer treatment.
  64. Hyatt John A., Water-dispersible or water-soluble D-tocotrienol compounds and methods for making therefor.
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로